Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

ROCHE HOLDING LTD. (ROG)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 10/20 05:30:07 pm
234.4 CHF   -1.76%
10/20 INOVIO PHARMACE : Begins Phase 1b/2 Cancer Efficacy Trial Combining ..
10/19DJEuropean Corporate Roundup for Thursday
10/19DJEuropean Corporate Roundup for Thursday
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M CHF Estimates in M CHF
Fiscal Period December 201420152016201720182019
Sales47 46248 14550 57653 41155 37757 256
EBITDA20 25919 47920 48321 45622 54623 601
Operating profit (EBIT)17 63617 54218 42018 40919 41120 275
Pre-Tax Profit (EBT)12 51511 98713 00715 59317 25218 226
Net income9 3328 8639 57611 15212 39313 086
P/E ratio25,026,920,917,516,015,9
EPS ( CHF )10,810,311,113,414,714,7
Dividend per Share ( CHF )8,008,108,208,599,029,41
Yield2,96%2,93%3,53%3,67%3,85%4,01%
Reference price ( CHF )269.9276.4232.6234.4234.4234.4
Announcement Date01/28/2015
12:22pm
01/28/2016
07:38am
02/01/2017
06:54am
---
Finances - Leverage
Actuals in M CHF Estimates in M CHF
Fiscal Period December 201420152016201720182019
Debt14 01114 08013 2489 8845 5071 534
Finance------
Operating income (EBITDA)20 25919 47920 48321 45622 54623 601
Leverage
(Debt/EBITDA)
0,69x0,72x0,65x0,46x0,24x0,07x
Capital Expenditure3 3343 4684 1443 9044 1354 239
Book Value Per Share (BVPS)23,1  CHF24,6  CHF28,1  CHF33,2  CHF38,6  CHF44,5  CHF
Cash Flow per Share18,5  CHF17,7  CHF17,4  CHF19,4  CHF20,1  CHF21,5  CHF
Announcement Date01/28/2015
12:22pm
01/28/2016
07:38am
02/01/2017
06:54am
---
Balance Sheet Analysis
Assessed data source :
© 2017 Thomson Reuters
Financial Ratios

Size 2017e 2018e
Capitalization 203 934 M CHF -
Entreprise Value (EV) 213 818 M CHF 209 441 M CHF
Valuation 2017e 2018e
P/E ratio (Price / EPS) 17,5x 16,0x
Capitalization / Revenue 3,82x 3,68x
EV / Revenue 4,00x 3,78x
EV / EBITDA 9,97x 9,29x
Yield (DPS / Price) 3,67% 3,85%
Price to book (Price / BVPS) 7,06x 6,07x
Profitability 2017e 2018e
Operating Margin (EBIT / Sales) 34,5% 35,1%
operating Leverage (Delta EBIT / Delta Sales) - 1,48x
Net Margin (Net Profit / Revenue) 20,9% 22,4%
ROA (Net Profit / Asset) 16,2% 17,1%
ROE (Net Profit / Equities) 46,3% 42,2%
Rate of Dividend 64,0% 61,5%
Balance Sheet Analysis 2017e 2018e
CAPEX / CA   7,31% 7,47%
Cash Flow / Sales 30,9% 30,9%
Capital Intensity (Assets / Sales) 1,29x 1,31x
Financial Leverage (Net Debt / EBITDA) 0,46x 0,24x
EPS & Dividend